Format

Send to:

Choose Destination
See comment in PubMed Commons below
Alzheimers Dement. 2010 May;6(3):297-9. doi: 10.1016/j.jalz.2010.03.011.

Japanese Alzheimer's Disease Neuroimaging Initiative: present status and future.

Author information

  • 1Department of Neuropathology, School of Medicine, University of Tokyo, Tokyo, Japan. iwatsubo@mol.f.u-tokyo.ac.jp

Abstract

Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI) was launched in 2008, aiming at conducting a longitudinal workup of a standardized neuroimaging, biomarker and clinico-psychological surveys. The research protocol was designed to maximize compatibility with that of US-ADNI, including structural magnetic resonance imaging analysis for the evaluation of brain atrophy, fluorodeoxyglucose and amyloid positron emission tomography, cerebrospinal fluid sampling, APOE genotyping, together with a set of clinical and psychometric tests that were prepared to achieve the highest compatibility to those used in the United States. Japanese ADNI has recruited approximately 357 participants (142 amnestic mild cognitive impairment, approximately 134 normal aged and 72 mild Alzheimer's disease (AD), as of April 15, 2010). World-wide ADNI activities will establish the rigorous quantitative descriptions of the natural course of AD in its very early stages. The data, as well as the methodologies and infrastructures, will facilitate the clinical trials of disease-modifying therapies for AD using surrogate biomarkers.

Copyright 2010 The Alzheimer

PMID:
20451880
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk